Skip to content

Clinical trials

Dermatitis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20181
20191
20211
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed2
Terminated2
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Novartis Pharmaceuticals2
Pfizer2
Beijing Zheng Ju Medical Technology Co., Ltd.1
Fuda Cancer Hospital, Guangzhou1
Prime Gene Therapeutics Co., Ltd.1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Suzhou Suncadia Biopharmaceuticals Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis12
Eczema7
Dermatitis, Atopic5
Immune System Diseases3
Skin Diseases2
Genetic Diseases, Inborn1
Hidradenitis1
Hidradenitis Suppurativa1
Hypersensitivity1
Hypersensitivity, Immediate1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.